Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model.

Acta Neuropathol Commun

Develomental Therapeutics and Pharmacology Unit, Surgical Neurology Branch, National Institute of Neurologic Disorders and Stroke (NINDS), NIH, Building 10, Room 7D45, 10 Center Drive, Bethesda, MD, 20892, USA.

Published: April 2024